| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.35 | 1e-16 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.46 | 3e-12 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-11 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-11 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-11 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.36 | 2e-10 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |